Theralase Technologies Inc (TLTFF)

[123414]

The way you look at the numbers is also good. I'm considering if they get 1 Canadian site with 5 patients by Q2 that's a great sampling. That would keep us in line with the timeline guidance.

Also for patient enrollment our completed Phase 1b safety trial and 66% CR at 12 months should factor in.

In the phase 1b study. People had to step forward to be the first "guinea pig" as we had not treated any humans with the procedure. So the, "Hey you go first factor" has been broken with great results. LOL

Patient treatment announcements could come at any time. Even as early as this week.